Treatment with HSP90 inhibitors, 17-AAG or 17-DMAG, was accompanied by downregulation of canonical MYC target genes, decreased tumor cell proliferation, cell cycle arrest, and increased apoptosis and necrosis. The gene discussed is MYC; the disease is neoplasm.